Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,748
Closed -$283K 551
2026
Q1
$283K Buy
+3,748
New +$282K 0.03% 388
2025
Q3
Sell
-3,274
Closed -$213K 410
2025
Q2
$213K Sell
3,274
-48
-1% -$2.88K 0.04% 350
2025
Q1
$205K Sell
3,322
-683
-17% -$45.3K 0.03% 483
2024
Q4
$289K Buy
4,005
+81
+2% +$6.33K 0.04% 369
2024
Q3
$320K Buy
3,924
+609
+18% +$48.7K 0.04% 363
2024
Q2
$246K Buy
3,315
+21
+0.6% +$1.57K 0.04% 363
2024
Q1
$257K Buy
3,294
+43
+1% +$3.2K 0.04% 352
2023
Q4
$232K Buy
3,251
+44
+1% +$3.06K 0.05% 345
2023
Q3
$223K Buy
+3,207
New +$242K 0.06% 327
2019
Q1
Sell
-3,218
Closed -$132K 496
2018
Q4
$132K Buy
+3,218
New +$132K 0.11% 179

Other funds holding HOLX

Claro Advisors's HOLX Position: Q2 2026 in Review

Claro Advisors sold out of Hologic (HOLX) in Q2 2026, closing a stake of 3,748 shares — an estimated $283K sold.

Claro Advisors first reported a position in HOLX in Q4 2018 and held it in 10 quarters. The position peaked at $320K in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Claro Advisors reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Claro Advisors sold 3,748 Hologic shares in Q2 2026, an estimated $283K.
  • Claro Advisors first reported a position in Hologic in Q4 2018 and held it in 10 quarters.
  • Claro Advisors's Hologic position peaked at $320K in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Claro Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.